Google on Tuesday announced a new set of artificial intelligence tools aimed at letting healthcare organizations use the search giant’s software and servers to read, store and label X-rays, MRIs and other medical imaging.
Unrealistic expectations are forcing some tech leaders to rethink cloud costs; ‘You discover your cloud architecture is immature when you’re surprised by the bill.’
New guidance from the Food and Drug Administration is triggering strong reaction from researchers and regulatory experts, who see it as an attempt to significantly expand the oversight of software tools used to guide clinical decisions.
Microsoft's chief information security officer Bret Arsenault joins The Post's Cat Zakrzewski to discuss strategies to succeed in the cloud, guard against cyber intrusions and the technological advances that could reshape the digital infrastructure of businesses in the coming decades.
The Food and Drug Administration on Tuesday published a list of artificial intelligence tools that should be regulated as medical devices, in some cases appearing to expand its oversight of previously unregulated software products.